Stay updated on Expanded Access Risdiplam in SMA Clinical Trial
Sign up to get notified when there's something new on the Expanded Access Risdiplam in SMA Clinical Trial page.

Latest updates to the Expanded Access Risdiplam in SMA Clinical Trial page
- Check4 days agoChange DetectedNo additions or deletions were detected between the old and new screenshots; the page content and layout appear unchanged.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedCore content updated with a government funding notice and a new Genetic and Rare Diseases Information Center resource; version updated from v3.1.0 to v3.2.0.SummaryDifference5%

- Check40 days agoChange DetectedVersion bump: from v3.0.2 to v3.1.0. No other content changes are specified.SummaryDifference0.1%

- Check54 days agoChange DetectedPage updated to Revision: v3.0.2 from v3.0.1; 'Back to Top' removed.SummaryDifference0.3%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check69 days agoChange DetectedThe web page has updated its facility name and location details, specifically highlighting St. Louis, Missouri, while removing several previous location descriptors and medical resources.SummaryDifference4%

Stay in the know with updates to Expanded Access Risdiplam in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access Risdiplam in SMA Clinical Trial page.